Literature DB >> 12189279

Decreased sensitivity of neonatal rabbit sarcoplasmic reticulum to anthracycline cardiotoxicity.

Brian E Burke1, Phillip S Mushlin, Barry J Cusack, Stephan J Olson, Herve A Gambliel, Ruchard D Olson.   

Abstract

Anthracyclines are useful chemotherapeutic agents whose utility is limited by the development of irreversible cardiotoxicity. When tested, the pediatric population demonstrates an increased sensitivity to the cardiotoxicity of this class of agents, although the reasons for this increased sensitivity are unclear. The sarcoplasmic reticulum (SR) is a target for anthracycline cardiotoxicity in adults, but the effects of anthracycline on the SR in developing myocardium have not been examined. It may be possible to gain insight into the mechanisms of cardiotoxicity through a comparative approach. We compared the acute effects of doxorubicin, daunorubicin, and caffeine on contractile function in adult and neonatal rabbit myocardium. Frequency-dependent contractility, 90% relaxation times, and postrest potentiated contractions (a uniquely SR-dependent phenomenon) in adult myocardium were inhibited in a concentration- dependent manner. Neonatal myocardium, however, was resistant to the effects of these agents. The degree of contractile dysfunction was consistent with the difference in SR maturation between adult and developing myocardium. Anthracyclines exhibited effects similar to those of caffeine, an agent known to render the SR nonfunctional by the depletion of the releasable SR calcium pool. These results suggest that anthracyclines induce acute cardiac lesions through effects on the SR in adults, whereas cardiotoxic effects in the developing myocardium may proceed by a different mechanism.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12189279     DOI: 10.1385/ct:2:1:41

Source DB:  PubMed          Journal:  Cardiovasc Toxicol        ISSN: 1530-7905            Impact factor:   3.231


  3 in total

Review 1.  Fibrates in the chemical action of daunorubicin.

Authors:  Ganesaratnam K Balendiran
Journal:  Curr Cancer Drug Targets       Date:  2009-05       Impact factor: 3.428

2.  Age-related differences in adriamycin-induced nephropathy.

Authors:  Hyewon Hahn; Young Seo Park; Il Soo Ha; Hae Il Cheong; Yong Choi
Journal:  Pediatr Nephrol       Date:  2004-05-11       Impact factor: 3.714

3.  TVP1022 protects neonatal rat ventricular myocytes against doxorubicin-induced functional derangements.

Authors:  Alexandra Berdichevski; Gideon Meiry; Felix Milman; Irena Reiter; Oshra Sedan; Sivan Eliyahu; Heather S Duffy; Moussa B Youdim; Ofer Binah
Journal:  J Pharmacol Exp Ther       Date:  2009-11-13       Impact factor: 4.030

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.